Immunomedics, Inc. (NASDAQ:IMMU) has a new drug candidate called IMMU-140 that is based on its antibody-drug conjugate (ADC) program. The company took the opportunity at the American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results